Antibiotic News and Research

RSS

Antibiotics are drugs used to treat infections caused by bacteria and other microorganisms.

Antibiotic resistance in cystic fibrosis linked to decreased microbial diversity and pulmonary function

A defective gene causes thick, sticky mucus to build up in the lungs of patients with cystic fibrosis. There, it traps bacteria, causing patients to develop frequent lung infections that progressively damage these vital organs and impair patients' ability to breathe.

27 Sep 2018

No scientific reason available to assume link between BPA uptake and MIH in children

Depending on symptomatic and phenotypic severity the condition of chalky teeth is categorised into three levels. The symptoms of chalky teeth were first described in 1978, with the term molar-incisor hypomineralisation introduced in 2001.

27 Sep 2018

Bacteria living inside the nose linked to type, severity of cold symptoms

In news with several layers of weird, researchers have determined that the mix of bacteria that live inside your nose - yes, there are organisms living inside your nose - correlates with the type and severity of cold symptoms you develop.

27 Sep 2018

Antibiotics actually kill 'good' bacteria and worsen oral infection, finds study

New research shows that the body's own microbes are effective in maintaining immune cells and killing certain oral infections.

26 Sep 2018

Pathogenic bacteria hibernate to escape antibiotic treatments

BACTERIA University of Copenhagen researchers have discovered a surprising tactic of pathogenic bacteria when being attacked by antibiotics: hibernation.

26 Sep 2018

Genomic ‘islands’ evolved from viruses can be converted into ‘anti-bacterial drones’

Genomic "islands" that evolved from viruses can be converted into "drones" that disable Staphylococcus aureus, bacteria that are often resistant to antibiotics and pose a threat to safe hospital care, a new study finds.

25 Sep 2018

New spinout company to tackle drug-resistant infections with novel antibiotics

Drug-resistant infections are set to kill more people than cancer by 2050. Now a new University of Plymouth spinout company has been established to help tackle the problem - by developing new antibiotics and bringing them to market.

24 Sep 2018

Innovation Fund Denmark supports research project that aims to fight Clostridium difficile diarrhea

One man's trash is another man's treasure, as the saying goes. If things go to plan, feces from registered and thoroughly tested healthy donors will in a few years be the standard treatment for the bacterium Clostridium difficile at Danish hospitals.

21 Sep 2018

Scientist intends to fight pathogenic bacteria with viruses

Dr. Li Deng of Helmholtz Zentrum München has been awarded a Starting Grant of the European Research Council. The scientist intends to tackle antimicrobial resistance by fighting bacteria with their natural enemies - the viruses. The grant is endowed with nearly 1.5 million euros for five years.

21 Sep 2018

Study highlights need to remain vigilant in maintaining key infection control processes

Healthcare-associated infections can be reduced by up to 55 percent by systematically implementing evidence-based infection prevention and control strategies, according to a review of 144 studies published today in Infection Control & Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.

21 Sep 2018

New naturally occurring antibiotic found effective against Mycobacterium tuberculosis

A naturally occurring antibiotic called kanglemycin A is effective against Mycobacterium tuberculosis, the bacteria that cause tuberculosis, even in drug-resistant strains, according to an international team of researchers who used chemistry, molecular biology, microbiology, and X-ray crystallography to show how the compound maintains its activity.

21 Sep 2018

Scientists achieve breakthrough in accelerated diagnosis of multi-resistant hospital pathogens

A team of researchers at the University of Cologne's Faculty of Medicine and the German Center for Infection Research has achieved a scientific breakthrough in the accelerated diagnosis of multi-resistant hospital pathogens.

20 Sep 2018

LineaRx signs agreement with Takis/Evvivax to develop linear-DNA based anti-cancer vaccines

Applied DNA Sciences Inc. announced today that LineaRx, Inc., its wholly-owned subsidiary focused on next-generation biotherapeutics, has signed a Joint Development Agreement with Takis S.R.L. and Evvivax S.R.L., biotechnology companies focused on the discovery and development of DNA based anti-cancer vaccines for the human and animal markets, respectively.

20 Sep 2018

Emergex signs MoU with Brazil’s Fiocruz for development of viral vaccines

Emergex Vaccines Holding Limited, a biotechnology company pioneering a new approach to synthetic vaccine development in the field of infectious diseases, today announces that it has signed a Memorandum of Understanding with Brazil-based Oswaldo Cruz Foundation 'Fiocruz' for the development of viral vaccines.

20 Sep 2018

Study finds factors within cell influencing variability in amount of protein produced

You can think of a cell in your body like a miniature factory, creating a final product called proteins, which carry out various tasks and functions.

20 Sep 2018

AmpliPhi receives positive feedback from FDA for its AB-PA01 product targeting P.aeruginosa infections

AmpliPhi Biosciences Corporation, a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, today announced that the company has received positive feedback, via written response, from the U.S. Food and Drug Administration regarding its development plans for AB-PA01, without the need for a Type B Pre-IND meeting.

19 Sep 2018

UTILITY receives FDA approval for Investigational New Drug applications

UTILITY therapeutics Ltd, a pharmaceutical company focused on developing and commercializing antibiotics in the US, today announces that the US Food and Drug Administration has approved the Investigational New Drug applications for mecillinam and pivmecillinam.

19 Sep 2018

First gut bacteria in newborns may have lasting effect on ability to ward off chronic diseases

New research showing that the first bacteria introduced into the gut have a lasting impact may one day allow science to adjust microbiomes--the one-of-a-kind microbial communities that live in our gastrointestinal tracts--to help ward off serious chronic diseases.

18 Sep 2018

Hospitalization after antibiotic initiation found to be higher for people with Alzheimer’s disease

Persons with Alzheimer's disease are more often hospitalized after antibiotic initiation than people without AD, a new study from the University of Eastern Finland shows.

18 Sep 2018

Probiotic supplementation may reduce use of antibiotics, scientific analysis shows

Global demand exists for new ways to reduce antibiotic use, given the urgent public health threat of antibiotic resistance.

17 Sep 2018

Antibiotic News and Research

Further Reading

Antibiotic resistance in cystic fibrosis linked to decreased microbial diversity and pulmonary function

No scientific reason available to assume link between BPA uptake and MIH in children

Bacteria living inside the nose linked to type, severity of cold symptoms

Antibiotics actually kill 'good' bacteria and worsen oral infection, finds study

Pathogenic bacteria hibernate to escape antibiotic treatments

Genomic ‘islands’ evolved from viruses can be converted into ‘anti-bacterial drones’

New spinout company to tackle drug-resistant infections with novel antibiotics

Innovation Fund Denmark supports research project that aims to fight Clostridium difficile diarrhea

Scientist intends to fight pathogenic bacteria with viruses

Study highlights need to remain vigilant in maintaining key infection control processes

New naturally occurring antibiotic found effective against Mycobacterium tuberculosis

Scientists achieve breakthrough in accelerated diagnosis of multi-resistant hospital pathogens

LineaRx signs agreement with Takis/Evvivax to develop linear-DNA based anti-cancer vaccines

Emergex signs MoU with Brazil’s Fiocruz for development of viral vaccines

Study finds factors within cell influencing variability in amount of protein produced

AmpliPhi receives positive feedback from FDA for its AB-PA01 product targeting P.aeruginosa infections

UTILITY receives FDA approval for Investigational New Drug applications

First gut bacteria in newborns may have lasting effect on ability to ward off chronic diseases

Hospitalization after antibiotic initiation found to be higher for people with Alzheimer’s disease

Probiotic supplementation may reduce use of antibiotics, scientific analysis shows

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News